Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01996982 · ClinicalTrials.gov registry record · NA

Study of a New Clinical Device for Reducing Body Core Temperature

A NA study, sponsored by Seton Healthcare Family.

Terminated
Registry status
NA
Development phase
7
Enrollment target

NCT01996982: Clinical Trial NA study, sponsored by Seton Healthcare Family.

NCT01996982 is a NA study that was terminated before completion, run by Seton Healthcare Family. The registered enrollment target is 7 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01996982, a NA study, was terminated before completion, sponsored by Seton Healthcare Family.

TERMINATED
Registry status
NA
Development phase
7 participants
Enrollment target

Study Summary

This is a descriptive, nonrandomized, noninvasive, single-group, single-center pilot study of a Core Cooling System (CCS) device for reducing core body temperature in ICU patients at University Medical Center Brackenridge (UMCB) and Seton Medical Center Austin (SMCA). The proposed research on human subjects will provide data that will be used to improve a specialized human heat transfer technique/device. By stimulating specialized blood vessels (arteriovenous anastomoses) AVAs in the palm of the hand, it is possible to greatly increase local blood flow and thus greatly increase the potential for effective heat transfer between the environment and body. The hypothesis of this trial is that the Core Cooling System (CCS) will prove to be a practical, safe, and effective method to raise or lower body temperature in critically ill patients.

Primary Outcome

1. Assess and capture all adverse events (if any) from application and use of the CCS device. 2. Also assess CCS device interference with participant's standard of care.

Interventions

  • DEVICE CCS Device

Trial Details

FieldValue
Enrollment Target 7 participants
Start Date 2014-03
Est. Completion 2015-07
Phase NA
Seton Healthcare Family

15 total trials

Why NCT01996982 stopped before completion

NCT01996982 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 1 intervention - of which CCS Device is the first listed.

NCT01996982 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01996982 about?

NCT01996982 is a clinical study titled "Study of a New Clinical Device for Reducing Body Core Temperature". This is a descriptive, nonrandomized, noninvasive, single-group, single-center pilot study of a Core Cooling System (CCS) device for reducing core body temperature in ICU patients at University Medical Center Brackenridge (UMCB) and Seton Medical Center Austin (SMCA). The proposed research on human ...

What is the current status of trial NCT01996982?

This trial is currently terminated. It is a NA study. The enrollment target is 7 participants. The study started on 2014-03. Estimated completion is 2015-07.

What interventions are being tested in trial NCT01996982?

The interventions under investigation include: CCS Device (DEVICE).

Who is sponsoring clinical trial NCT01996982?

This trial is sponsored by Seton Healthcare Family, which has 15 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01996982's enrollment target sits among peer trials

7 1982nd of 2000 higher than 18 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01996982, the US trial registry maintained by the National Library of Medicine. NCT01996982 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.